Godspower Akpomiemie

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase”.

Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase

Nature Communications(2020)10.1038/s41467-020-19801-x

N/A

4.0DataRank · unranked

83 citations

Michelle Moorhouse, Bryony Simmons, Túlio de Oliveira, Richard Lessells, Jennifer Giandhari +8 more

Determinants of early change in serum creatinine after initiation of dolutegravir‐based antiretroviral therapy in South Africa

British Journal of Clinical Pharmacology(2024)10.1111/bcp.16009

N/A

0.394DataRank · unranked

8 citations

Aida N. Kawuma, Roeland E. Wasmann, Godspower Akpomiemie, Nomathemba Chandiwana, Simiso Sokhela +9 more

Weight and Metabolic Changes After Switching From Tenofovir Alafenamide/Emtricitabine (FTC)+Dolutegravir (DTG), Tenofovir Disoproxil Fumarate (TDF)/FTC + DTG, and TDF/FTC/Efavirenz to TDF/Lamivudine/DTG

Clinical Infectious Diseases(2022)10.1093/cid/ciac949

N/A

0DataRank · unranked

57 citations

Godspower Akpomiemie, Nomathemba Chandiwana, Simiso Sokhela, Andrew Hill, Kaitlyn McCann +4 more

Pharmacokinetic and pharmacogenetic associations with dolutegravir neuropsychiatric adverse events in an African population

Journal of Antimicrobial Chemotherapy(2022)10.1093/jac/dkac290

N/A

0DataRank · unranked

9 citations

Phumla Sinxadi, Aida N. Kawuma, John A. Joska, Simiso Sokhela, Godspower Akpomiemie +5 more